To study blood levels of this growth factor in subjects without metabolic syndrome and their association with the new onset of metabolic disturbances, together with its interrelation with other important explanatory variables, such as physical activity or the underlying inflammatory state of people, may represent a first step towards a better understanding of the complex role of VEGFb in human physiology. This evidence concerns the gene VEGFB and metabolic syndrome.